Nirmanmoh Bhatia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nirmanmoh Bhatia has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Sahil Agrawal
Department of Cardiology, St. Luke's University Health Network, Bethlehem, Pennsylvania
12 shared publications Divyanshu Mohananey
Division of Hospital Medicine, Cleveland Clinic, Cleveland, OH
7 shared publications- Arash Nayeri
Department of Civil Engineering, Arak Branch, Islamic Azad University, Arak, Iran
6 shared publications - Divyanshu Mohananey
Medical College of Wisconsin Cardiovascular Center , Milwaukee, WI
6 shared publications - Manyoo Agarwal
Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
6 shared publications Sahil Agrawal
Department of Cardiovascular Medicine, St. Lukes University Health Network, Bethlehem, PA
6 shared publications
Latest Publications
- 1 January 2020
- Published by Elsevier in The American Journal of Cardiology
- Vol. 125 (1) , 135-139
Comparison of Transcatheter Pulmonic Valve Implantation With Surgical Pulmonic Valve Replacement in Adults (from the National Inpatient Survey Dataset)
- 1 January 2020
- Published by Elsevier in The American Journal of Cardiology
- Vol. 125 (1) , 135-139
Comparison of Transcatheter Pulmonic Valve Implantation With Surgical Pulmonic Valve Replacement in Adults (from the National Inpatient Survey Dataset)
- 1 October 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (5) , 2423-2434
Heart Failure With Preserved Ejection Fraction—A Systematic Review and Analysis of Perioperative Outcomes
- 1 October 2018
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 32 (5) , 2423-2434
Heart Failure With Preserved Ejection Fraction—A Systematic Review and Analysis of Perioperative Outcomes
- 1 August 2018
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 11 (15) , 1534-1535
Emergent Percutaneous Closure of Left Ventricular Free Wall Perforation During Transcatheter Aortic Valve Replacement
- 1 August 2018
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 11 (15) , 1534-1535
Emergent Percutaneous Closure of Left Ventricular Free Wall Perforation During Transcatheter Aortic Valve Replacement
- 1 March 2018
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 19 (2) , 201-203
Aortic pseudoaneurysm & endocarditis caused by Aerococcus viridans: A case report and literature review
- 1 March 2018
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 19 (2) , 201-203
Aortic pseudoaneurysm & endocarditis caused by Aerococcus viridans: A case report and literature review
- 1 January 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (1) , 32-40
Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting
- 1 January 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (1) , 32-40
Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting
- 1 October 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (8) , 1355-1358
In-Hospital Outcomes of Transcatheter Aortic Valve Implantation in Patients With End-Stage Renal Disease on Dialysis from a Large National Database
- 1 October 2017
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (8) , 1355-1358
In-Hospital Outcomes of Transcatheter Aortic Valve Implantation in Patients With End-Stage Renal Disease on Dialysis from a Large National Database
- 28 August 2017
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 30 (5) , 397-404
Staged versus index procedure complete revascularization in ST‐elevation myocardial infarction: A meta‐analysis
Background: Complete revascularization of patients with ST‐elevation myocardial infarction and multivessel coronary artery disease reduces adverse events compared to infarct‐related artery only revascularization. Whether complete revascularization should be done as multivessel intervention during index procedure or as a staged procedure remains controversial.Method: We performed a meta‐analysis of randomized controlled trials comparing outcomes of multivessel intervention in patients with ST‐elevation myocardial infarction and multivessel coronary artery disease as staged procedure versus at the time of index procedure. Composite of death or myocardial infarction was the primary outcome. Mantel‐Haenszel risk ratios were calculated using random effect model.Results: Six randomized studies with a total of 1126 patients met our selection criteria. At a mean follow‐up of 13 months, composite of myocardial infarction or death (7.2% vs 11.7%, RR: 1.66, 95%CI: 1.09‐2.52, P = 0.02), all cause mortality (RR: 2.55, 95%CI: 1.42‐4.58, P < 0.01), cardiovascular mortality (RR: 2.8, 95%CI: 1.33‐5.86, P = 0.01), and short‐term (P < 0.01) occurred less often in staged versus index procedure multivessel revascularization. There was no difference in major adverse cardiac events (RR: 1.14, 95%CI: 0.88‐1.49, P = 0.33), repeat myocardial infarction (RR: 1.14, 95%CI: 0.68‐1.92, P = 0.61), and repeat revascularization (RR: 0.92, 95%CI: 0.66‐1.28, P = 0.62).Conclusion: In patients with ST‐elevation myocardial infarction and multivessel coronary artery disease, a strategy of complete revascularization as a staged procedure compared to index procedure revascularization results in reduced mortality without an increase in repeat myocardial infarction or need for repeat revascularization.
- 28 August 2017
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 30 (5) , 397-404
Staged versus index procedure complete revascularization in ST‐elevation myocardial infarction: A meta‐analysis
Background: Complete revascularization of patients with ST‐elevation myocardial infarction and multivessel coronary artery disease reduces adverse events compared to infarct‐related artery only revascularization. Whether complete revascularization should be done as multivessel intervention during index procedure or as a staged procedure remains controversial.Method: We performed a meta‐analysis of randomized controlled trials comparing outcomes of multivessel intervention in patients with ST‐elevation myocardial infarction and multivessel coronary artery disease as staged procedure versus at the time of index procedure. Composite of death or myocardial infarction was the primary outcome. Mantel‐Haenszel risk ratios were calculated using random effect model.Results: Six randomized studies with a total of 1126 patients met our selection criteria. At a mean follow‐up of 13 months, composite of myocardial infarction or death (7.2% vs 11.7%, RR: 1.66, 95%CI: 1.09‐2.52, P = 0.02), all cause mortality (RR: 2.55, 95%CI: 1.42‐4.58, P < 0.01), cardiovascular mortality (RR: 2.8, 95%CI: 1.33‐5.86, P = 0.01), and short‐term (P < 0.01) occurred less often in staged versus index procedure multivessel revascularization. There was no difference in major adverse cardiac events (RR: 1.14, 95%CI: 0.88‐1.49, P = 0.33), repeat myocardial infarction (RR: 1.14, 95%CI: 0.68‐1.92, P = 0.61), and repeat revascularization (RR: 0.92, 95%CI: 0.66‐1.28, P = 0.62).Conclusion: In patients with ST‐elevation myocardial infarction and multivessel coronary artery disease, a strategy of complete revascularization as a staged procedure compared to index procedure revascularization results in reduced mortality without an increase in repeat myocardial infarction or need for repeat revascularization.